RIBHI HAZIN: Open Payments
NPI 1265747463 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 151 payments from 25 companies in 2025. Trend: 2023 $1,404 · 2024 $2,423 · 2025 $2,957
Food & beverage: $2,957
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $551 |
| Lundbeck LLC | 24 | $388 |
| Alkermes, Inc. | 16 | $271 |
| ABBVIE INC. | 15 | $257 |
| Teva Pharmaceuticals USA, Inc. | 11 | $245 |
| Axsome Therapeutics, Inc. | 9 | $189 |
| Neurelis, Inc. | 7 | $149 |
| GlaxoSmithKline, LLC. | 7 | $117 |
| Novo Nordisk Inc | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
Products named: REXULTI, ARISTADA, AIRSUPRA, AUSTEDO XR, Auvelity, VRAYLAR, VALTOCO, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
